319 related articles for article (PubMed ID: 37511507)
1. The P2X7 Receptor, a Multifaceted Receptor in Alzheimer's Disease.
Ronning KE; Déchelle-Marquet PA; Che Y; Guillonneau X; Sennlaub F; Delarasse C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511507
[TBL] [Abstract][Full Text] [Related]
2. The P2X7 receptor: a new therapeutic target in Alzheimer's disease.
Illes P; Rubini P; Huang L; Tang Y
Expert Opin Ther Targets; 2019 Mar; 23(3):165-176. PubMed ID: 30691318
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
6. Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression.
Qin J; Zhang X; Wang Z; Li J; Zhang Z; Gao L; Ren H; Qian M; Du B
Sci China Life Sci; 2017 Feb; 60(2):189-201. PubMed ID: 28120269
[TBL] [Abstract][Full Text] [Related]
7. New role of P2X7 receptor in an Alzheimer's disease mouse model.
Martin E; Amar M; Dalle C; Youssef I; Boucher C; Le Duigou C; Brückner M; Prigent A; Sazdovitch V; Halle A; Kanellopoulos JM; Fontaine B; Delatour B; Delarasse C
Mol Psychiatry; 2019 Jan; 24(1):108-125. PubMed ID: 29934546
[TBL] [Abstract][Full Text] [Related]
8. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus.
McLarnon JG; Ryu JK; Walker DG; Choi HB
J Neuropathol Exp Neurol; 2006 Nov; 65(11):1090-7. PubMed ID: 17086106
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
Van Zeller M; Dias D; Sebastião AM; Valente CA
J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
[TBL] [Abstract][Full Text] [Related]
10. P2X7-dependent immune pathways in retinal diseases.
Déchelle-Marquet PA; Guillonneau X; Sennlaub F; Delarasse C
Neuropharmacology; 2023 Feb; 223():109332. PubMed ID: 36372269
[TBL] [Abstract][Full Text] [Related]
11. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
Zheng H; Liu Q; Zhou S; Luo H; Zhang W
Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of P2X7 and P2Y2 nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells.
León-Otegui M; Gómez-Villafuertes R; Díaz-Hernández JI; Díaz-Hernández M; Miras-Portugal MT; Gualix J
FEBS Lett; 2011 Jul; 585(14):2255-62. PubMed ID: 21651910
[TBL] [Abstract][Full Text] [Related]
13. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.
Bianchi C; Alvarez-Castelao B; Sebastián-Serrano Á; Di Lauro C; Soria-Tobar L; Nicke A; Engel T; Díaz-Hernández M
Alzheimers Res Ther; 2023 Jun; 15(1):105. PubMed ID: 37287063
[TBL] [Abstract][Full Text] [Related]
15. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.
Chen YH; Lin RR; Tao QQ
Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia.
Rampe D; Wang L; Ringheim GE
J Neuroimmunol; 2004 Feb; 147(1-2):56-61. PubMed ID: 14741428
[TBL] [Abstract][Full Text] [Related]
17. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
[TBL] [Abstract][Full Text] [Related]
18. Activation of microglia by amyloid {beta} requires P2X7 receptor expression.
Sanz JM; Chiozzi P; Ferrari D; Colaianna M; Idzko M; Falzoni S; Fellin R; Trabace L; Di Virgilio F
J Immunol; 2009 Apr; 182(7):4378-85. PubMed ID: 19299738
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
20. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
